Dr. Dubinett is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10833 Le Conte Avenue
43-229 CHS
Los Angeles, CA 90095Phone+1 310-267-2725Fax+1 310-267-2725
Education & Training
Harvard Medical SchoolFellowship, Cancer Immunology, 1986 - 1988
Massachusetts General Hospital/BIDMC/Harvard Medical SchoolResidency, Pulmonary Disease and Critical Care Medicine, 1985 - 1988
UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1981 - 1984
Rutgers Health/New Jersey Medical SchoolInternship, Internal Medicine, 1980 - 1981- Rutgers New Jersey Medical SchoolClass of 1980
Certifications & Licensure
CA State Medical License 1981 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy Start of enrollment: 2007 Mar 30
- DECAMP-1: Diagnosis and Surveillance of Indeterminate Pulmonary Nodules Start of enrollment: 2013 Jan 01
- DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers Start of enrollment: 2020 Aug 24
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- 231 citationsCancer and inflammation: Promise for biologic therapySandra Demaria, Eli Pikarsky, Michael Karin, Lisa M. Coussens, Yen-Ching Chen
Journal of Immunotherapy. 2010-05-01 - 32 citationsIL-20, an anti-angiogenic cytokine that inhibits COX-2 expression ☆ ☆☆Nathalie Heuzé-Vourc'h, Ming Liu, Harnisha Dalwadi, Felicita Baratelli, Li Zhu
Biochemical and Biophysical Research Communications. 2005-07-29 - 21 citationsMutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44Amy L. Cummings, Jaklin Gukasyan, Henry Lu, Tristan Grogan, Gemalene Sunga
Nature Cancer. 2020-11-16
Journal Articles
- Functional Profiling of Circulating Tumor Cells with an Integrated Vortex Capture and Single-Cell Protease Activity AssaySteven M Dubinett, Matthew B Rettig, Proceedings of the National Academy of Sciences
Press Mentions
Genetically Engineered Dendritic Cells Enhance the Power of Immunotherapy Against Lung CancerMarch 26th, 2024- Marc Lenburg, PhD, Receives $4.6M NIH Grant to Better Identify Lung CancerOctober 17th, 2022
- L.A. Care Health Plan - 25 Years StrongJuly 22nd, 2022
- Join now to see all
Grant Support
- Intratumoral Genetic Therapy For Lung CancerVeterans Affairs2012
- UCLA Tumor Immunology Training ProgramNational Cancer Institute2012
- Inflammation In The Pathogenesis Of Lung CancerVeterans Affairs2011–2012
- UCLA Clinical And Translational Science InstituteNational Center For Research Resources2011
- CTSA Infrastructure For Pediatric ResearchNational Center For Research Resources2011
- CTSA Infrastructure For Clinical TrialsNational Center For Research Resources2011
- CTSA Infrastructure For AIDS ResearchNational Center For Research Resources2011
- The UCLA - Boston University Lung Cancer Biomarker Development LaboratoryNational Cancer Institute2010–2011
- Thoracic OncologyNational Cancer Institute2009–2011
- Pulmonary And Critical Care Medicine Training ProgramNational Heart, Lung, And Blood Institute2006–2011
- Tumor Immunology Institutional Training GrantNational Cancer Institute2006–2010
- Novel COX-2 And Pge2-Dependent Pathways In Lung CancerNational Cancer Institute2006–2010
- UCLA Spore In Lung CancerNational Cancer Institute2001–2008
- A Phase I Trial Of Ccl-21 Gene Modified DC In NsclcNational Cancer Institute2003–2007
- New Pathways In IL7 Mediated Antifibrotic ResponsesNational Heart, Lung, And Blood Institute2002–2005
- Genetic Immunotherapy For Lung CancerNational Cancer Institute2001–2004
- Dendritic Cell-Based Genetic Immunotherapy /Lung CancerNational Cancer Institute2001–2002
- New Pathways In IL7 Mediated Antifibrotic ResponsesNational Heart, Lung, And Blood Institute2001
- Function And Regulation Of IL 10 In Lung CancerNational Cancer Institute1997–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
